NCT05835518View on ClinicalTrials.gov

An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

January 26, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

August 31, 2026

Conditions

Rheumatoid ArthritisAnkylosing Spondylitis

Trial Locations (1)

Unknown

RECRUITING

Daegu Catholic University Medical Center, Daegu

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY